Laboratory services poised for the digital revolution
The clinical trials landscape is evolving more rapidly than ever before. The COVID-19 pandemic and geopolitical instability have put new…
All articles by Juliet Martin
Juliet Martin
-
-
Trends in global vaccine development: 2023 and beyond
The global vaccine development landscape has been subject to unprecedented upheaval in recent years. The COVID-19 pandemic accelerated technological adoption…
-
How automating clinical trial payments can unlock end-to-end efficiencies
Traditional approaches to payment management for clinical trials are highly manual, labour-intensive, and subject to human error. In an industry…
-
Asia Pacific dominates Phase I clinical trials: a trend analysis
The global landscape for Phase I clinical trials is changing, and over the last ten years, the APAC region has…
-
Using analytics and bioassays to de-risk your mRNA LNP drug development programme
The swift development and deployment of messenger-RNA (mRNA) vaccines against the SARS-CoV-2 virus during the COVID-19 crisis has catapulted the…
-
Growth opportunities: The clinical trials landscape of Asia-Pacific
The global clinical trials landscape has seen continued growth between 2017 and 2022. While all regions have faced significant disruption,…
-
The top five global biotech trends of the last five years
The biotechnology and pharmaceutical landscape has faced unprecedented disruption in the last five years, and the future remains uncertain. Shifting…
-
War in Ukraine: What it means for clinical trial operations
Russia’s full-scale invasion of Ukraine in February has had local, regional and global ramifications for clinical trial operations. Alongside its…
-
How to navigate changes in the global clinical trial map
Changes in the geography of clinical trials have been exacerbated by recent geopolitical events. As the shift gathers momentum, emerging…
-
New territories: Challenges and benefits for western biotechs in China
Increasingly, pharmaceutical companies around the world are looking to capitalise on value creation across different geographic regions through the utilisation…